Furthermore, significant downregulation of Bcl-2 and upregulation of Bax were observed in glioma cells treated with α-m-Dox/M, which may be mediated by the p53 pathway because of the elevated level of the p53 protein46. The gene discussed is BCL2; the disease is central nervous system cancer.